Showing results (6241-6250 of 27,720) with videos related to

Sort By:
Pageof 2,772
Vaccine|January 11, 2025
Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccineYoshikazu Honda-Okubo, Utsav Vaghasiya, Nikolai Petrovsky
Vaccine|January 4, 2025
A framework for monitoring RSV prevention product effectiveness in the United StatesLauren E Roper, Ruth Link-Gelles, Diya Surie, et al.
Vaccine|January 10, 2025
Optimizing hepatitis B virus seroprotection in thoracic organ transplantation: The role of HepB-CpG (Heplisav-B) vaccination scheduleChia-Yu Chiu, Priya Sampathkumar, Lisa M Brumble, et al.
Vaccine|January 5, 2025
RSV immunization uptake among infants and pregnant persons - Wisconsin, October 1, 2023-March 31, 2024Maddie Kemp, Ashley Capriola, Stephanie Schauer
Vaccine|January 4, 2025
Trends in costs of routinely recommended vaccines in the United States, 2001-2023RajReni Kaul, Andrew J Leidner, Harrell W Chesson
Vaccine|January 2, 2025
Receipt of respiratory vaccines among patients with heart failure in a multicenter health system registryAnna Dermenchyan, Kristen R Choi, Pooya R Bokhoor, et al.
Vaccine|March 13, 2025
A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccineFederico Martinón-Torres, Silvina Natalini Martinez, Mary J Kline, et al.
Vaccine|March 7, 2025
Associated factors for dropout of first versus third doses of pentavalent vaccination in TanzaniaRobert Tillya, Gumi Abdallah, Hajirani Msuya, et al.
Vaccine|March 7, 2025
Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in UgandaAndrew M Abaasa, Sylvia Kusemererwa, Violet Ankunda, et al.
Vaccine|March 7, 2025
Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in CanadaRaphael Ximenes, Alison E Simmons, Gebremedhin B Gebretekle, et al.
Pageof 2,772